WTA
SANA icon

Washington Trust Advisors’s Sana Biotechnology SANA Stock Holding History

Washington Trust Advisors’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.4K Hold
5,000
– – ﹤0.01% 465
2026
Q1 		$14.4K Hold
5,000
– – ﹤0.01% 457
2025
Q4 		$20.4K Buy
+5,000
New +$22.4K ﹤0.01% 439

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Washington Trust Advisors's SANA Position: Q2 2026 in Review

Washington Trust Advisors held its Sana Biotechnology (SANA) position steady in Q2 2026 at 5,000 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #465.

Washington Trust Advisors first reported a position in SANA in Q4 2025 and has held it in 3 quarters since. The position peaked at $20.4K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Washington Trust Advisors held 5,000 shares of Sana Biotechnology worth $17.4K as of Q2 2026.
  • Washington Trust Advisors left its Sana Biotechnology share count unchanged in Q2 2026.
  • Sana Biotechnology made up ﹤0.01% of Washington Trust Advisors's portfolio in Q2 2026, its #465 holding.
  • Washington Trust Advisors first reported a position in Sana Biotechnology in Q4 2025 and has held it in 3 quarters since.
  • Washington Trust Advisors's Sana Biotechnology position peaked at $20.4K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.